Rhumbline Advisers Atrion Corp Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$381.09 - $495.99 $139,478 - $181,532	-366 Reduced 5.18%	6,693 $3.03 Million
Q1 2024 May 09, 2024	BUY	$308.3 - $463.55 $470,465 - $707,377	1,526 Added 27.58%	7,059 $3.27 Million
Q4 2023 Feb 08, 2024	SELL	$289.29 - $409.7 $106,458 - $150,769	-368 Reduced 6.24%	5,533 $2.1 Million
Q3 2023 Nov 09, 2023	SELL	$401.2 - $581.79 $20,461 - $29,671	-51 Reduced 0.86%	5,901 $2.44 Million
Q2 2023 Aug 08, 2023	BUY	$500.0 - $659.0 $44,500 - $58,651	89 Added 1.52%	5,952 $3.37 Million
Q1 2023 May 11, 2023	SELL	$565.0 - $694.87 $18,080 - $22,235	-32 Reduced 0.54%	5,863 $3.68 Million
Q4 2022 Feb 14, 2023	BUY	$551.1 - $688.5 $23,697 - $29,605	43 Added 0.73%	5,895 $3.3 Million
Q3 2022 Nov 10, 2022	BUY	$545.43 - $680.3 $191,991 - $239,465	352 Added 6.4%	5,852 $3.31 Million
Q2 2022 Aug 11, 2022	BUY	$605.0 - $763.25 $46,585 - $58,770	77 Added 1.42%	5,500 $3.46 Million
Q1 2022 May 12, 2022	SELL	$601.4 - $763.0 $543,665 - $689,752	-904 Reduced 14.29%	5,423 $3.87 Million
Q4 2021 Feb 10, 2022	SELL	$650.15 - $802.0 $111,825 - $137,944	-172 Reduced 2.65%	6,327 $4.46 Million
Q3 2021 Nov 12, 2021	BUY	$594.24 - $758.0 $474,203 - $604,884	798 Added 14.0%	6,499 $4.53 Million
Q2 2021 Aug 05, 2021	SELL	$582.88 - $670.99 $177,778 - $204,651	-305 Reduced 5.08%	5,701 $3.54 Million
Q1 2021 May 06, 2021	SELL	$619.2 - $736.0 $383,284 - $455,584	-619 Reduced 9.34%	6,006 $3.85 Million
Q4 2020 Feb 10, 2021	SELL	$576.6 - $672.2 $9,802 - $11,427	-17 Reduced 0.26%	6,625 $4.26 Million
Q3 2020 Nov 12, 2020	SELL	$620.1 - $689.89 $2.39 Million - $2.66 Million	-3,854 Reduced 36.72%	6,642 $4.16 Million
Q2 2020 Aug 13, 2020	BUY	$610.05 - $713.9 $71,375 - $83,526	117 Added 1.13%	10,496 $6.69 Million
Q1 2020 May 06, 2020	BUY	$615.5 - $751.4 $2.13 Million - $2.6 Million	3,460 Added 50.01%	10,379 $6.75 Million
Q4 2019 Feb 05, 2020	SELL	$688.5 - $846.15 $9,639 - $11,846	-14 Reduced 0.2%	6,919 $5.2 Million
Q3 2019 Oct 23, 2019	BUY	$722.04 - $840.0 $1.43 Million - $1.66 Million	1,976 Added 39.86%	6,933 $5.4 Million
Q2 2019 Aug 14, 2019	BUY	$837.83 - $927.0 $499,346 - $552,492	596 Added 13.67%	4,957 $4.23 Million
Q1 2019 May 01, 2019	SELL	$709.9 - $885.4 $1.22 Million - $1.52 Million	-1,717 Reduced 28.25%	4,361 $3.83 Million
Q4 2018 Jan 31, 2019	BUY	$667.94 - $785.7 $400,096 - $470,634	599 Added 10.93%	6,078 $4.5 Million
Q3 2018 Nov 07, 2018	BUY	$602.8 - $699.6 $760,733 - $882,895	1,262 Added 29.93%	5,479 $3.81 Million
Q2 2018 Aug 06, 2018	BUY	$568.25 - $635.8 $11,933 - $13,351	21 Added 0.5%	4,217 $2.53 Million
Q1 2018 May 02, 2018	BUY	$526.8 - $633.85 $220,729 - $265,583	419 Added 11.09%	4,196 $2.65 Million
Q4 2017 Feb 09, 2018	SELL	$620.6 - $689.35 $282,373 - $313,654	-455 Reduced 10.75%	3,777 $2.38 Million
Q3 2017 Nov 06, 2017	BUY	$608.7 - $680.0 $2.58 Million - $2.88 Million	4,232	4,232 $2.84 Million

Others Institutions Holding ATRI

# of Institutions

Shares Held

114K

Call Options Held

Put Options Held

View Full List

About ATRION CORP

Ticker ATRI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 1,785,990
Description
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...

More about ATRI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account